Omega Therapeutics, Inc. Common Stock
OMGA
OMGA was delisted on the 24th of February, 2025.
63 hedge funds and large institutions have $152M invested in Omega Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 10 closing their positions.
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
38% more capital invested
Capital invested by funds: $109M → $152M (+$42.1M)
9% more funds holding
Funds holding: 58 → 63 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
21% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 19
49% less call options, than puts
Call options by funds: $61K | Put options by funds: $119K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOCH
Blue Owl Capital Holdings
New York
|
+$2.14M |
| 2 |
Citigroup
New York
|
+$969K |
| 3 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$621K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$605K |
| 5 |
Morgan Stanley
New York
|
+$200K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$2.45M |
| 2 |
6CM
683 Capital Management
New York
|
-$797K |
| 3 |
Millennium Management
New York
|
-$376K |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$372K |
| 5 |
BlackRock
New York
|
-$299K |
OMGA Hedge Fund Activity: Q4 2023 in Review
63 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q4 2023, worth a combined $152M — up 38% from $109M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new OMGA positions and 10 closed out — a net gain of 6 holders — while 15 added to existing stakes and 19 trimmed.
The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $2.14M. The largest seller was Artal Group, cutting an estimated $2.45M.
- 63 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q4 2023, up from 58 in Q3 2023.
- Funds reported $152M of Omega Therapeutics, Inc. Common Stock stock for Q4 2023, up 38% quarter-over-quarter.
- 16 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q4 2023 and 10 closed out, a net change of +6 holders.
- The largest Omega Therapeutics, Inc. Common Stock buyer in Q4 2023 was Blue Owl Capital Holdings, an estimated $2.14M added.
- The largest Omega Therapeutics, Inc. Common Stock seller in Q4 2023 was Artal Group, an estimated $2.45M sold.
Based on aggregated 13F filings for Q4 2023.